Back to Rankings

MYO

MyomoC
NYSE American / Health Care Equipment & Services
Last Price
At close
2026-06-03
View Chart
Current thesis
The bull case is that March 2026 marked a real access and mix inflection: 2025 revenue still grew 26% to $40.9 million, recurring patient sources reached 42% of Q4 revenue, Q4 authorizations/orders hit a record 241, and the Elevance rollout could materially widen covered lives if conversion follows [#PR-2026-03-09-Earnings] [#PR-2026-03-09-Elevance].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Elevance agreement may take time to become effective market by market and may not translate into near-term orders [#PR-2026-03-09-Elevance].
Momentum
79
Value
36
Sentiment
32
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.90 · Bull $1.60 · Bear $0.40
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum79 · Δ7d -
Value36 · Δ7d -0.0
Sentiment32 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
79
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
32
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 79.0 / Value 36.3 / Sentiment 31.5

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$40.96M
Beta
1.16
Shares Out
38.44M
P/E (TTM) · Derived
-6.7
P/S (TTM)
1.00
P/FCF (TTM) · Derived
-3.16
Rev YoY
+9.6%
EPS YoY
-241.2%
Gross Margin
+66.6%
Op Margin
-28.5%
Net Debt
-$24.87M
Current Ratio
2.49
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology